The venture was found in North America in United States. The main department of described VC is located in the Hanover.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Helix, Vets First Choice, Flurry For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Construction, Information Technology. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The fund was created by Jesse Devitte, Matt Harris, Phil Ferneau. Besides them, we counted 4 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Borealis Ventures, startups are often financed by North Bridge Venture Partners & Growth Equity, Kodiak Venture Partners, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are North Bridge Venture Partners & Growth Equity, Kodiak Venture Partners, Village Ventures. In the next rounds fund is usually obtained by Building Ventures, North Bridge Venture Partners & Growth Equity, Kodiak Venture Partners.
Comparing to the other companies, this Borealis Ventures performs on 11 percentage points less the average number of lead investments. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2017. The usual things for fund are deals in the range of 5 - 10 millions dollars. The typical startup value when the investment from Borealis Ventures is 10-50 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
Fund Name | Location |
Alerion Partners | Connecticut, Darien, United States |
CalCEF Clean Energy Angel Fund | California, San Francisco, United States |
Coconut Tree Investments | - |
DLJDirect | England, Leeds, United Kingdom |
Futuristic.vc | Copenhagen, Denmark, Hovedstaden |
Great Pacific Securities | - |
Jiaxing Canshi Lukejiuhao Touzi Guanli Hehuo Qiye (Limited Partnership) | China, Jiaxing, Zhejiang |
Liberty Financial Companies, Inc | Boston, Massachusetts, United States |
Life Sciences Alternative Funding | New York, United States, White Plains |
Mezzetti Advisory Group. | Italy, Lombardy, Milan |
Mix Labs | - |
NextTech Group of Technopreneurs | Hanoi, Vietnam |
Schurz Communications | Indiana, Mishawaka, United States |
Seven Tree Equity Partners | - |
Shangcap Partners | - |
Shenzhen Xiaoxi Holdings | - |
Solidity Ventures | - |
Tameny | Japan, Tokyo |
Whittier Ventures | Boston, Massachusetts, United States |
Zhongjing Ruiyi | Beijing, China, Pinggu |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Ankyra | $45M | 12 Nov 2021 | Boston, Massachusetts, United States | ||
Orbit Discovery | $7M | 20 Jul 2021 | Oxford, England, United Kingdom | ||
Ovation | $21M | 16 Dec 2020 | Cambridge, Massachusetts, United States | ||
FidoCure | $10M | 29 Oct 2020 | Palo Alto, California, United States | ||
Ovation | $5M | 14 Mar 2019 | Cambridge, Massachusetts, United States | ||
Teckro | $25M | 14 Feb 2019 | New York, New York, United States | ||
Evox Therapeutics | $47M | 02 Sep 2018 | Oxford, England, United Kingdom | ||
Compass Therapeutics | $49M | 12 Jul 2018 | Boston, Massachusetts, United States | ||
Orbit Discovery | $9M | 23 May 2018 | Oxford, England, United Kingdom |
– Orbit Discovery has raised $7.6m in funding.
– The financing was led by Oxford Sciences Innovation with participation from Borealis Ventures, Perivoli Innovations, and other institutional and individual investors, including Kapil Dev Joory.
– Proceeds from the financing will be used to accelerate Orbit’s growth trajectory as a leading provider of peptide discovery services to the biotechnology and pharmaceutical industry.
– Orbit’s novel bead-based and microfluidic technology platform enables the screening of peptide libraries for target binding and subsequent activity in cell-based functional assays.
– This makes the platform ideal for identifying active peptides against both soluble proteins and membrane bound targets such as GPCRs.
– Until now, researchers have struggled to unite high throughput affinity screens with functional screens utilising peptide libraries of very high chemical diversity.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Ankyra | $45M | 12 Nov 2021 | Boston, Massachusetts, United States | ||
Orbit Discovery | $7M | 20 Jul 2021 | Oxford, England, United Kingdom | ||
Ovation | $21M | 16 Dec 2020 | Cambridge, Massachusetts, United States | ||
FidoCure | $10M | 29 Oct 2020 | Palo Alto, California, United States | ||
Ovation | $5M | 14 Mar 2019 | Cambridge, Massachusetts, United States | ||
Teckro | $25M | 14 Feb 2019 | New York, New York, United States | ||
Evox Therapeutics | $47M | 02 Sep 2018 | Oxford, England, United Kingdom | ||
Compass Therapeutics | $49M | 12 Jul 2018 | Boston, Massachusetts, United States | ||
Orbit Discovery | $9M | 23 May 2018 | Oxford, England, United Kingdom |